NASDAQ:BRKR - Bruker Stock Price, News & Analysis

$41.47
+1.51 (+3.78 %)
(As of 08/18/2019 06:49 AM ET)
Today's Range
$40.06
Now: $41.47
$41.76
50-Day Range
$39.64
MA: $46.85
$51.01
52-Week Range
$26.10
Now: $41.47
$51.41
Volume1.29 million shs
Average Volume1.12 million shs
Market Capitalization$6.41 billion
P/E Ratio29.62
Dividend Yield0.40%
Beta1.3
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.90 billion
Cash Flow$1.8910 per share
Book Value$5.63 per share

Profitability

Net Income$179.70 million

Miscellaneous

Employees6,870
Market Cap$6.41 billion
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.


Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Monday, August 12th. Shareholders of record on Tuesday, September 3rd will be paid a dividend of $0.04 per share on Friday, September 20th. This represents a $0.16 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Friday, August 30th. View Bruker's Dividend History.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) issued its quarterly earnings results on Thursday, August, 1st. The medical research company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.02. The medical research company had revenue of $490.20 million for the quarter, compared to the consensus estimate of $477.70 million. Bruker had a net margin of 9.57% and a return on equity of 27.10%. The firm's revenue was up 10.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.25 EPS. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY19 earnings guidance on Thursday, August, 1st. The company provided earnings per share (EPS) guidance of $1.57-1.61 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.62. The company issued revenue guidance of $2.028-2.048 billion, compared to the consensus revenue estimate of $2.04 billion.

What price target have analysts set for BRKR?

11 brokerages have issued 1-year target prices for Bruker's shares. Their forecasts range from $32.00 to $57.00. On average, they anticipate Bruker's share price to reach $49.20 in the next year. This suggests a possible upside of 18.6% from the stock's current price. View Analyst Price Targets for Bruker.

What is the consensus analysts' recommendation for Bruker?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 4 hold ratings, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.

Has Bruker been receiving favorable news coverage?

News headlines about BRKR stock have trended negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Bruker earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned media coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Bruker.

Are investors shorting Bruker?

Bruker saw a decrease in short interest in July. As of July 31st, there was short interest totalling 1,715,200 shares, a decrease of 16.2% from the June 30th total of 2,046,400 shares. Based on an average daily trading volume, of 859,700 shares, the short-interest ratio is presently 2.0 days. Approximately 1.7% of the shares of the stock are sold short. View Bruker's Current Options Chain.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Advanced Micro Devices (AMD), Thermo Fisher Scientific (TMO), Abbott Laboratories (ABT), Ciena (CIEN), General Electric (GE), Costco Wholesale (COST), Cisco Systems (CSCO), Illumina (ILMN), Intel (INTC) and Netflix (NFLX).

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Dr. Falko Busse, Exec. Officer (Age 52)

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (19.20%), Vanguard Group Inc. (6.93%), BlackRock Inc. (3.32%), Acadian Asset Management LLC (2.40%), Janus Henderson Group PLC (2.13%) and Janus Henderson Group PLC (2.13%). Company insiders that own Bruker stock include Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Acadian Asset Management LLC, Point72 Asset Management L.P., Marshall Wace North America L.P., BNP Paribas Arbitrage SA, Allianz Asset Management GmbH, Russell Investments Group Ltd. and Man Group plc. Company insiders that have sold Bruker company stock in the last year include Frank H Laukien and Marc A Kastner. View Insider Buying and Selling for Bruker.

Which institutional investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Nuveen Asset Management LLC, APG Asset Management N.V., First Trust Advisors LP, Sector Gamma AS, Price T Rowe Associates Inc. MD, Los Angeles Capital Management & Equity Research Inc. and Vanguard Group Inc.. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $41.47.

How big of a company is Bruker?

Bruker has a market capitalization of $6.41 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.

What is Bruker's official website?

The official website for Bruker is http://www.bruker.com/.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  571 (Vote Outperform)
Underperform Votes:  620 (Vote Underperform)
Total Votes:  1,191
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel